Department of Internal Medicine, Brigham and Women's Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States.
Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States.
Trends Cardiovasc Med. 2020 Feb;30(2):104-112. doi: 10.1016/j.tcm.2019.03.007. Epub 2019 Apr 2.
Acute heart failure (AHF) is one of the most common causes for hospital admission and is associated with a high risk of mortality. Compared to chronic heart failure, there is less robust evidence to guide diagnosis, risk stratification and management of AHF. This state-of-the art review aims to summarize new developments in this field. We also highlight areas of ongoing work including novel vasoactive agents, alternative models to traditional hospital admission and strategies to improve patient engagement.
急性心力衰竭（AHF）是住院的最常见原因之一，与高死亡率相关。与慢性心力衰竭相比，指导 AHF 的诊断、风险分层和管理的证据不够充分。本综述旨在总结该领域的新进展。我们还强调了正在进行的工作领域，包括新型血管活性药物、传统住院替代模型以及提高患者参与度的策略。
